nodes	percent_of_prediction	percent_of_DWPC	metapath
Norethindrone—ALB—Crohn's disease	0.327	1	CbGaD
Norethindrone—Danazol—Prednisone—Crohn's disease	0.136	0.317	CrCrCtD
Norethindrone—Cortisone acetate—Prednisone—Crohn's disease	0.114	0.267	CrCrCtD
Norethindrone—Methyltestosterone—Prednisone—Crohn's disease	0.0968	0.226	CrCrCtD
Norethindrone—Hydrocortisone—Prednisone—Crohn's disease	0.081	0.189	CrCrCtD
Norethindrone—CYP3A5—Sulfasalazine—Crohn's disease	0.0455	0.288	CbGbCtD
Norethindrone—ALB—Prednisone—Crohn's disease	0.0453	0.287	CbGbCtD
Norethindrone—CYP2C19—Prednisone—Crohn's disease	0.0293	0.186	CbGbCtD
Norethindrone—ABCB1—Prednisone—Crohn's disease	0.0237	0.15	CbGbCtD
Norethindrone—CYP3A4—Prednisone—Crohn's disease	0.0142	0.0898	CbGbCtD
Norethindrone—Carbohydrate tolerance decreased—Prednisone—Crohn's disease	0.00442	0.0506	CcSEcCtD
Norethindrone—Infertility—Mesalazine—Crohn's disease	0.00401	0.0459	CcSEcCtD
Norethindrone—Breast feeding—Mesalazine—Crohn's disease	0.003	0.0343	CcSEcCtD
Norethindrone—Erythema nodosum—Mesalazine—Crohn's disease	0.00242	0.0277	CcSEcCtD
Norethindrone—Prurigo—Mesalazine—Crohn's disease	0.00227	0.026	CcSEcCtD
Norethindrone—Abdominal bloating—Mesalazine—Crohn's disease	0.0022	0.0252	CcSEcCtD
Norethindrone—Hirsutism—Mesalazine—Crohn's disease	0.0018	0.0206	CcSEcCtD
Norethindrone—Gastrointestinal symptom NOS—Mesalazine—Crohn's disease	0.00178	0.0204	CcSEcCtD
Norethindrone—Abdominal cramps—Mesalazine—Crohn's disease	0.00155	0.0178	CcSEcCtD
Norethindrone—Thrombosis—Mesalazine—Crohn's disease	0.00148	0.0169	CcSEcCtD
Norethindrone—Metrorrhagia—Mesalazine—Crohn's disease	0.00147	0.0168	CcSEcCtD
Norethindrone—Dermatitis atopic—Mesalazine—Crohn's disease	0.00141	0.0162	CcSEcCtD
Norethindrone—Menorrhagia—Mesalazine—Crohn's disease	0.00141	0.0162	CcSEcCtD
Norethindrone—Neoplasm malignant—Azathioprine—Crohn's disease	0.00135	0.0154	CcSEcCtD
Norethindrone—Jaundice cholestatic—Azathioprine—Crohn's disease	0.00131	0.015	CcSEcCtD
Norethindrone—Breast disorder—Mercaptopurine—Crohn's disease	0.00127	0.0145	CcSEcCtD
Norethindrone—Acne—Mesalazine—Crohn's disease	0.00124	0.0143	CcSEcCtD
Norethindrone—Tenderness—Mesalazine—Crohn's disease	0.0012	0.0137	CcSEcCtD
Norethindrone—Breast pain—Mesalazine—Crohn's disease	0.0012	0.0137	CcSEcCtD
Norethindrone—Amenorrhoea—Mesalazine—Crohn's disease	0.00119	0.0136	CcSEcCtD
Norethindrone—Jaundice cholestatic—Mesalazine—Crohn's disease	0.00119	0.0136	CcSEcCtD
Norethindrone—Hepatobiliary disease—Mercaptopurine—Crohn's disease	0.00102	0.0117	CcSEcCtD
Norethindrone—Menstruation irregular—Prednisone—Crohn's disease	0.001	0.0115	CcSEcCtD
Norethindrone—Hirsutism—Prednisone—Crohn's disease	0.000953	0.0109	CcSEcCtD
Norethindrone—Optic neuritis—Prednisone—Crohn's disease	0.000901	0.0103	CcSEcCtD
Norethindrone—Immune system disorder—Mercaptopurine—Crohn's disease	0.000875	0.01	CcSEcCtD
Norethindrone—Photosensitivity—Mesalazine—Crohn's disease	0.000866	0.00991	CcSEcCtD
Norethindrone—Embolism—Prednisone—Crohn's disease	0.000863	0.00988	CcSEcCtD
Norethindrone—Alopecia—Mercaptopurine—Crohn's disease	0.000856	0.0098	CcSEcCtD
Norethindrone—Renal impairment—Mesalazine—Crohn's disease	0.000799	0.00915	CcSEcCtD
Norethindrone—Dermatitis atopic—Prednisone—Crohn's disease	0.000749	0.00857	CcSEcCtD
Norethindrone—Migraine—Mesalazine—Crohn's disease	0.000748	0.00857	CcSEcCtD
Norethindrone—Affect lability—Mesalazine—Crohn's disease	0.000748	0.00857	CcSEcCtD
Norethindrone—Mood swings—Mesalazine—Crohn's disease	0.00072	0.00825	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Mercaptopurine—Crohn's disease	0.000713	0.00817	CcSEcCtD
Norethindrone—Oedema—Mercaptopurine—Crohn's disease	0.000688	0.00788	CcSEcCtD
Norethindrone—Breast disorder—Mesalazine—Crohn's disease	0.000687	0.00787	CcSEcCtD
Norethindrone—Skin disorder—Mercaptopurine—Crohn's disease	0.000669	0.00766	CcSEcCtD
Norethindrone—Abdominal distension—Mesalazine—Crohn's disease	0.000661	0.00757	CcSEcCtD
Norethindrone—Acne—Prednisone—Crohn's disease	0.000659	0.00754	CcSEcCtD
Norethindrone—Amenorrhoea—Prednisone—Crohn's disease	0.000631	0.00722	CcSEcCtD
Norethindrone—Hepatobiliary disease—Azathioprine—Crohn's disease	0.000608	0.00697	CcSEcCtD
Norethindrone—Photosensitivity reaction—Mesalazine—Crohn's disease	0.0006	0.00687	CcSEcCtD
Norethindrone—Weight increased—Mesalazine—Crohn's disease	0.000598	0.00685	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Mercaptopurine—Crohn's disease	0.000594	0.00681	CcSEcCtD
Norethindrone—Depression—Mesalazine—Crohn's disease	0.000584	0.00669	CcSEcCtD
Norethindrone—Haemoglobin—Azathioprine—Crohn's disease	0.00058	0.00664	CcSEcCtD
Norethindrone—Haemorrhage—Azathioprine—Crohn's disease	0.000577	0.00661	CcSEcCtD
Norethindrone—Renal failure—Mesalazine—Crohn's disease	0.000576	0.00659	CcSEcCtD
Norethindrone—Hepatobiliary disease—Mesalazine—Crohn's disease	0.000554	0.00634	CcSEcCtD
Norethindrone—Erythema multiforme—Azathioprine—Crohn's disease	0.000546	0.00625	CcSEcCtD
Norethindrone—Haemoglobin—Mesalazine—Crohn's disease	0.000529	0.00605	CcSEcCtD
Norethindrone—Hepatitis—Mesalazine—Crohn's disease	0.000526	0.00602	CcSEcCtD
Norethindrone—Haemorrhage—Mesalazine—Crohn's disease	0.000526	0.00602	CcSEcCtD
Norethindrone—Immune system disorder—Azathioprine—Crohn's disease	0.000522	0.00597	CcSEcCtD
Norethindrone—Connective tissue disorder—Mesalazine—Crohn's disease	0.000517	0.00592	CcSEcCtD
Norethindrone—Alopecia—Azathioprine—Crohn's disease	0.00051	0.00584	CcSEcCtD
Norethindrone—Hypersensitivity—Mercaptopurine—Crohn's disease	0.000507	0.00581	CcSEcCtD
Norethindrone—Erythema multiforme—Mesalazine—Crohn's disease	0.000497	0.00569	CcSEcCtD
Norethindrone—Immune system disorder—Mesalazine—Crohn's disease	0.000475	0.00544	CcSEcCtD
Norethindrone—Alopecia—Mesalazine—Crohn's disease	0.000465	0.00532	CcSEcCtD
Norethindrone—Thrombophlebitis—Prednisone—Crohn's disease	0.000465	0.00532	CcSEcCtD
Norethindrone—Mental disorder—Mesalazine—Crohn's disease	0.000461	0.00528	CcSEcCtD
Norethindrone—Flatulence—Mesalazine—Crohn's disease	0.000451	0.00517	CcSEcCtD
Norethindrone—Tension—Mesalazine—Crohn's disease	0.000449	0.00514	CcSEcCtD
Norethindrone—Nervousness—Mesalazine—Crohn's disease	0.000445	0.00509	CcSEcCtD
Norethindrone—Vomiting—Mercaptopurine—Crohn's disease	0.000438	0.00501	CcSEcCtD
Norethindrone—Rash—Mercaptopurine—Crohn's disease	0.000434	0.00497	CcSEcCtD
Norethindrone—Dermatitis—Mercaptopurine—Crohn's disease	0.000434	0.00497	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Azathioprine—Crohn's disease	0.000425	0.00487	CcSEcCtD
Norethindrone—Purpura—Prednisone—Crohn's disease	0.000417	0.00478	CcSEcCtD
Norethindrone—Nausea—Mercaptopurine—Crohn's disease	0.000409	0.00468	CcSEcCtD
Norethindrone—Skin disorder—Azathioprine—Crohn's disease	0.000398	0.00456	CcSEcCtD
Norethindrone—Affect lability—Prednisone—Crohn's disease	0.000396	0.00453	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Mesalazine—Crohn's disease	0.000387	0.00443	CcSEcCtD
Norethindrone—Mood swings—Prednisone—Crohn's disease	0.000381	0.00436	CcSEcCtD
Norethindrone—Oedema—Mesalazine—Crohn's disease	0.000374	0.00428	CcSEcCtD
Norethindrone—Anaphylactic shock—Mesalazine—Crohn's disease	0.000374	0.00428	CcSEcCtD
Norethindrone—Skin disorder—Mesalazine—Crohn's disease	0.000363	0.00416	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Azathioprine—Crohn's disease	0.000354	0.00406	CcSEcCtD
Norethindrone—Abdominal distension—Prednisone—Crohn's disease	0.00035	0.00401	CcSEcCtD
Norethindrone—Insomnia—Mesalazine—Crohn's disease	0.000338	0.00387	CcSEcCtD
Norethindrone—Gastrointestinal pain—Azathioprine—Crohn's disease	0.000335	0.00384	CcSEcCtD
Norethindrone—Somnolence—Mesalazine—Crohn's disease	0.000332	0.0038	CcSEcCtD
Norethindrone—Dyspepsia—Mesalazine—Crohn's disease	0.000329	0.00377	CcSEcCtD
Norethindrone—Abdominal pain—Azathioprine—Crohn's disease	0.000324	0.00371	CcSEcCtD
Norethindrone—Gastrointestinal disorder—Mesalazine—Crohn's disease	0.000323	0.00369	CcSEcCtD
Norethindrone—Fatigue—Mesalazine—Crohn's disease	0.000322	0.00369	CcSEcCtD
Norethindrone—Weight increased—Prednisone—Crohn's disease	0.000316	0.00362	CcSEcCtD
Norethindrone—Depression—Prednisone—Crohn's disease	0.000309	0.00354	CcSEcCtD
Norethindrone—Acute coronary syndrome—Prednisone—Crohn's disease	0.000306	0.0035	CcSEcCtD
Norethindrone—Gastrointestinal pain—Mesalazine—Crohn's disease	0.000306	0.0035	CcSEcCtD
Norethindrone—Myocardial infarction—Prednisone—Crohn's disease	0.000304	0.00348	CcSEcCtD
Norethindrone—Hypersensitivity—Azathioprine—Crohn's disease	0.000302	0.00346	CcSEcCtD
Norethindrone—Urticaria—Mesalazine—Crohn's disease	0.000297	0.0034	CcSEcCtD
Norethindrone—Abdominal pain—Mesalazine—Crohn's disease	0.000295	0.00338	CcSEcCtD
Norethindrone—Haemoglobin—Prednisone—Crohn's disease	0.00028	0.0032	CcSEcCtD
Norethindrone—Haemorrhage—Prednisone—Crohn's disease	0.000278	0.00319	CcSEcCtD
Norethindrone—Hypersensitivity—Mesalazine—Crohn's disease	0.000275	0.00315	CcSEcCtD
Norethindrone—Connective tissue disorder—Prednisone—Crohn's disease	0.000273	0.00313	CcSEcCtD
Norethindrone—Dizziness—Azathioprine—Crohn's disease	0.000271	0.00311	CcSEcCtD
Norethindrone—Asthenia—Mesalazine—Crohn's disease	0.000268	0.00307	CcSEcCtD
Norethindrone—Pruritus—Mesalazine—Crohn's disease	0.000264	0.00303	CcSEcCtD
Norethindrone—Vomiting—Azathioprine—Crohn's disease	0.000261	0.00299	CcSEcCtD
Norethindrone—Rash—Azathioprine—Crohn's disease	0.000259	0.00296	CcSEcCtD
Norethindrone—Dermatitis—Azathioprine—Crohn's disease	0.000258	0.00296	CcSEcCtD
Norethindrone—Headache—Azathioprine—Crohn's disease	0.000257	0.00294	CcSEcCtD
Norethindrone—Immune system disorder—Prednisone—Crohn's disease	0.000251	0.00288	CcSEcCtD
Norethindrone—Dizziness—Mesalazine—Crohn's disease	0.000247	0.00283	CcSEcCtD
Norethindrone—Alopecia—Prednisone—Crohn's disease	0.000246	0.00282	CcSEcCtD
Norethindrone—Mental disorder—Prednisone—Crohn's disease	0.000244	0.00279	CcSEcCtD
Norethindrone—Nausea—Azathioprine—Crohn's disease	0.000244	0.00279	CcSEcCtD
Norethindrone—Vomiting—Mesalazine—Crohn's disease	0.000238	0.00272	CcSEcCtD
Norethindrone—Rash—Mesalazine—Crohn's disease	0.000236	0.0027	CcSEcCtD
Norethindrone—Dermatitis—Mesalazine—Crohn's disease	0.000235	0.0027	CcSEcCtD
Norethindrone—Headache—Mesalazine—Crohn's disease	0.000234	0.00268	CcSEcCtD
Norethindrone—Nausea—Mesalazine—Crohn's disease	0.000222	0.00254	CcSEcCtD
Norethindrone—Convulsion—Prednisone—Crohn's disease	0.00021	0.0024	CcSEcCtD
Norethindrone—Unspecified disorder of skin and subcutaneous tissue—Prednisone—Crohn's disease	0.000205	0.00235	CcSEcCtD
Norethindrone—Testosterone—SLC22A4—Crohn's disease	0.000203	0.453	CrCbGaD
Norethindrone—Oedema—Prednisone—Crohn's disease	0.000198	0.00226	CcSEcCtD
Norethindrone—Anaphylactic shock—Prednisone—Crohn's disease	0.000198	0.00226	CcSEcCtD
Norethindrone—Skin disorder—Prednisone—Crohn's disease	0.000192	0.0022	CcSEcCtD
Norethindrone—Insomnia—Prednisone—Crohn's disease	0.000179	0.00205	CcSEcCtD
Norethindrone—Dyspepsia—Prednisone—Crohn's disease	0.000174	0.00199	CcSEcCtD
Norethindrone—Fatigue—Prednisone—Crohn's disease	0.00017	0.00195	CcSEcCtD
Norethindrone—Gastrointestinal pain—Prednisone—Crohn's disease	0.000162	0.00185	CcSEcCtD
Norethindrone—Urticaria—Prednisone—Crohn's disease	0.000157	0.0018	CcSEcCtD
Norethindrone—Abdominal pain—Prednisone—Crohn's disease	0.000156	0.00179	CcSEcCtD
Norethindrone—Hypersensitivity—Prednisone—Crohn's disease	0.000146	0.00167	CcSEcCtD
Norethindrone—Asthenia—Prednisone—Crohn's disease	0.000142	0.00162	CcSEcCtD
Norethindrone—Pruritus—Prednisone—Crohn's disease	0.00014	0.0016	CcSEcCtD
Norethindrone—Dizziness—Prednisone—Crohn's disease	0.000131	0.0015	CcSEcCtD
Norethindrone—Drospirenone—PTGS2—Crohn's disease	0.00013	0.291	CrCbGaD
Norethindrone—Vomiting—Prednisone—Crohn's disease	0.000126	0.00144	CcSEcCtD
Norethindrone—Rash—Prednisone—Crohn's disease	0.000125	0.00143	CcSEcCtD
Norethindrone—Dermatitis—Prednisone—Crohn's disease	0.000125	0.00143	CcSEcCtD
Norethindrone—Headache—Prednisone—Crohn's disease	0.000124	0.00142	CcSEcCtD
Norethindrone—Nausea—Prednisone—Crohn's disease	0.000117	0.00134	CcSEcCtD
Norethindrone—Methyltestosterone—ALB—Crohn's disease	7.28e-05	0.163	CrCbGaD
Norethindrone—Testosterone—ALB—Crohn's disease	4.22e-05	0.0943	CrCbGaD
